Markets
Stocks
Mutual Funds & ETF's
Sectors
Investing Tools
Overview
Market News
Analysts
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
Local Stocks
DUSA PHARMACEUTICLS (NQ: DUSA)
+0.0600 (+4.412%)
at
1.42
49,230 in Volume
Add to:
My Watchlist
Data as of 03:17 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 1.400
Bid (Size) 1.400 (8600)
Ask (Size) 1.420 (6500)
Prev. Close 1.360
Today's Range 1.370 - 1.420
52wk Range 0.8800 - 1.870
Shares Outstanding 24,108,908
Morningstar Profile
View Full Profile
DUSA PHARMACEUTICLS
A vertically integrated dermatology company that is engaged in the development and marketing of Levulan PDT and other products for common skin conditions.
Healthcare
Drug Manufacturers - Other
Exchange Traded NQ
Market Cap 34.23M
Related Companies IPHAF INSV MS PRM
Top News
Read More
DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Feb 02, 2010
from PRNewsWire News Releases
DUSA Pharmaceuticals (DUSA) Up On Reports of FDA Approval   
Dec 18, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5196461 for the full story. Read More
from StreetInsider.com News Articles
More News
Read More
Dusa Pharma moves up on FDA approval speculation   
Dec 18, 2009
category Hot Stocks
from theflyonthewall.com
Most Recent Ebitda data for DUSA Pharmaceuticals now available   
Nov 18, 2009
category Stocks
from StockTrendNews.com eb RSS Feed
Free-Cash-News makes most recent Free Cash Flow metrics available for DUSA Pharmaceuticals   
Nov 16, 2009
category Stocks
from StockTrendNews.com fc RSS Feed
T12-NEWS Releases Comparative Revenue Results for DUSA Pharmaceuticals and Pharmaceuticals Industry   
Nov 16, 2009
category Stocks
from StockTrendNews.com sli RSS Feed
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
© Copyright FinancialContent, Inc.